Reaction Details Report a problem with these data
Target
Cyclin-dependent kinase 9
Ligand
BDBM454573
Substrate
n/a
Meas. Tech.
Kinase Assay (ATP Concentration at Km)
IC50
<3.00±n/a nM
Citation
 Barlaam, B; De Savi, C; Hawkins, J; Hird, A; Lamb, M; Pike, K; Vasbinder, M Chemical compounds US Patent  US10717746 Publication Date 7/21/2020 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM454573
Synonyms:
US10717746, Example 53
Type:
Small organic molecule
Emp. Form.:
C25H32ClN5O3
Mol. Mass.:
486.006
SMILES:
CC1(C)Cc2c(cnn2C1)-c1cc(NC(=O)[C@H]2CCC[C@H](C2)NC(=O)[C@@H]2C[C@H](O)C2)ncc1Cl |r,wD:16.17,20.24,25.27,27.30,(-1.68,4.97,;-3.02,4.2,;-1.68,3.43,;-3.49,2.73,;-5.03,2.73,;-6.28,1.83,;-7.52,2.73,;-7.05,4.2,;-5.51,4.2,;-4.26,5.1,;-6.28,.29,;-4.94,-.48,;-4.94,-2.02,;-3.61,-2.79,;-2.28,-2.02,;-2.28,-.48,;-.94,-2.79,;-.94,-4.33,;.39,-5.1,;1.72,-4.33,;1.72,-2.79,;.39,-2.02,;3.06,-2.02,;4.39,-2.79,;4.39,-4.33,;5.73,-2.02,;6.12,-.53,;7.61,-.93,;8.95,-.16,;7.21,-2.42,;-6.28,-2.79,;-7.61,-2.02,;-7.61,-.48,;-8.95,.29,)|
Structure:
Search PDB for entries with ligand similarity: